SAKATA, Y. Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1M tegaful-0.4M gimestat-1M otastat potassium) in advanced gastric cancer patients. Eur J Cancer. 1998, 34, 1715-1720
KOIZUMI, W. Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer. Oncology. 2000, 58, 191-197